INmune Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	24.75	20.92	35.85	52.15	74.81
Cash & Short-Term Investments	24.75	20.92	35.85	52.15	74.81
Cash Growth	18.30%	-41.64%	-31.26%	-30.29%	240.56%
Other Receivables	4.54	1.41	2.44	8.46	5.5
Total Trade Receivables	4.54	1.41	2.44	8.46	5.5
Other Current Assets	0.6	0.33	1.65	4.06	2.29
Total Current Assets	29.89	22.66	39.94	64.68	82.61
Net Property, Plant & Equipment	1.87	0.31	0.41	0.51	0.73
Other Intangible Assets	-	16.51	16.51	16.51	16.51
Other Long-Term Assets	0.6	0.08	0.13	0.1	0.1
Total Assets	32.35	39.56	57	81.8	99.95
Accounts Payable	7.79	6.56	7.94	5.22	3.81
Accrued Expenses	7.79	6.56	7.94	5.22	3.81
Current Portion of Long-Term Debt	-	-	9.92	5	-
Current Portion of Leases	0.62	0.14	0.12	0.09	0.07
Other Current Liabilities	-	0.52	0.49	0.62	0.47
Total Current Liabilities	8.42	7.22	18.47	10.92	4.36
Long-Term Debt	-	-	-	9.7	14.46
Long-Term Leases	0.41	0.24	0.4	0.53	0.7
Other Long-Term Liabilities	-	-	-	0.55	0.2
Total Long-Term Liabilities	0.41	0.24	0.4	10.77	15.36
Total Liabilities	8.83	7.47	18.86	21.69	19.72
Common Stock	0.03	0.02	0.02	0.02	0.02
Additional Paid-in Capital	233.27	195.75	159.14	151.8	143.92
Accumulated Other Comprehensive Income	-0.74	-0.58	-0.8	-0.7	0
Retained Earnings	-	-	-121.02	-91.01	-63.72
Total Common Shareholders' Equity	232.56	195.2	37.34	60.1	80.23
Minority Interest	-	-	0.8	-	-
Shareholders' Equity	232.56	195.2	38.14	60.1	80.23
Total Liabilities & Equity	32.35	39.56	57	81.8	99.95
Total Debt	1.03	0.38	10.44	15.31	15.23
Net Cash (Debt)	23.72	20.54	25.41	36.84	59.58
Net Cash Growth	15.48%	-19.18%	-31.03%	-38.16%	173.20%
Net Cash Per Share	0.96	1.03	1.41	2.06	3.69
Book Value	232.56	195.2	37.34	60.1	80.23
Book Value Per Share	9.39	9.79	2.08	3.35	4.97
Tangible Book Value	232.56	178.69	20.83	43.59	63.71
Tangible Book Value Per Share	9.39	8.96	1.16	2.43	3.95

Updated Mar 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q